Localization of Usher syndrome type II to chromosome 1q.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMID 2347588)

Published in Genomics on June 01, 1990

Authors

W J Kimberling1, M D Weston, C Möller, S L Davenport, Y Y Shugart, I A Priluck, A Martini, M Milani, R J Smith

Author Affiliations

1: Center for Hereditary Communication Disorders, Boys Town National Research Hospital, Omaha, Nebraska 68131.

Articles citing this

Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II. Am J Hum Genet (2004) 2.15

Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76

Usher syndrome in the city of Birmingham--prevalence and clinical classification. Br J Ophthalmol (1997) 1.46

Mouse model for Usher syndrome: linkage mapping suggests homology to Usher type I reported at human chromosome 11p15. Proc Natl Acad Sci U S A (1995) 1.33

Genetic heterogeneity of Usher syndrome: analysis of 151 families with Usher type I. Am J Hum Genet (2000) 1.29

Sensorineural deafness inherited as a tissue specific mitochondrial disorder. J Med Genet (1992) 1.24

Genetic deafness. J Med Genet (1992) 1.18

Gene mapping of Usher syndrome type IIa: localization of the gene to a 2.1-cM segment on chromosome 1q41. Am J Hum Genet (1995) 1.14

Tightly linked flanking microsatellite markers for the Usher syndrome type I locus on the short arm of chromosome 11. Am J Hum Genet (1994) 1.14

Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene. Am J Hum Genet (1999) 1.13

Early diagnosis of Usher syndrome in children. Trans Am Ophthalmol Soc (2000) 1.10

Genetic heterogeneity of Usher syndrome type II. J Med Genet (1993) 1.06

The genetics of deafness. Arch Dis Child (1990) 0.95

Genetic heterogeneity of Usher syndrome type II in a Dutch population. J Med Genet (1996) 0.93

Linkage analysis in Usher syndrome type I (USH1) families from Spain. J Med Genet (1998) 0.89

Usher syndrome type III (USH3) linked to chromosome 3q in an Italian family. J Med Genet (1998) 0.86

Recent advances in the gene map of inherited eye disorders: primary hereditary diseases of the retina, choroid, and vitreous. J Med Genet (1994) 0.83

Pendred syndrome: evidence for genetic homogeneity and further refinement of linkage. J Med Genet (1997) 0.82

Molecular genetics of retinitis pigmentosa. West J Med (1991) 0.79

Clinical and molecular genetic characterisation of a family segregating autosomal dominant retinitis pigmentosa and sensorineural deafness. Br J Ophthalmol (1997) 0.77

Evidence for a fourth locus in Usher syndrome type I. J Med Genet (1996) 0.77

Contig maps and genomic sequencing identify candidate genes in the usher 1C locus. Genome Res (1998) 0.75

A novel zinc finger gene on human chromosome 1qter that is alternatively spliced in human tissues and cell lines. Am J Hum Genet (1993) 0.75

Articles by these authors

Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature (1995) 5.91

Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum (1997) 5.57

Perspectives on the basic reproductive ratio. J R Soc Interface (2005) 5.34

Value-based pathology: a cost-benefit analysis of the examination of routine and nonroutine tonsil and adenoid specimens. Am J Clin Pathol (1997) 4.51

Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55

Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet (2000) 3.48

Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet (2000) 3.39

CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) (1998) 3.33

Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet (1997) 3.19

Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum (1991) 2.91

Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol (2001) 2.85

Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science (1998) 2.84

Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet (1997) 2.82

The gut: a central organ after surgical stress. Surgery (1988) 2.76

Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer (2006) 2.71

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest (1995) 2.66

Diabetes mellitus and peripheral vascular disease: is aspirin effective in preventing vascular events? Diabetologia (1996) 2.59

Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA (1999) 2.56

Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol (2001) 2.55

Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52

Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48

Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35

Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int (2001) 2.19

Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16

Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet (1997) 2.15

Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest (1997) 2.11

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy (2007) 2.10

A re-examination of risk estimates from the NIOSH Occupational Noise and Hearing Survey (ONHS) J Acoust Soc Am (1997) 2.09

Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07

Oral challenge tests for urticaria--an ethical dilemma. Br J Dermatol (1994) 1.98

Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene (2010) 1.93

Pattern formation in the blue-green alga, Anabaena. I. Basic mechanisms. J Cell Sci (1973) 1.92

Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest (1998) 1.91

Camptodactyly and simialr atraumatic flexion deformities of the proximal interphalangeal joints of the fingers. A study of thirty-one cases. J Bone Joint Surg Am (1968) 1.89

Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88

CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet (2002) 1.86

Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82

Eye signs in craniopharyngioma. Br J Ophthalmol (1975) 1.80

Linkage of Usher syndrome type I gene (USH1B) to the long arm of chromosome 11. Genomics (1992) 1.79

High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79

Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med (2001) 1.78

Pattern formation in the blue-green alga Anabaena. II. Controlled proheterocyst regression. J Cell Sci (1973) 1.78

Recurrent meningitis and Mondini dysplasia. Arch Otolaryngol Head Neck Surg (1990) 1.77

Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat (2001) 1.77

Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76

Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr (1985) 1.71

Teratogenicity of 2-ethoxyethanol by dermal application. Drug Chem Toxicol (1982) 1.70

Localization of the Usher syndrome type ID gene (Ush1D) to chromosome 10. Hum Mol Genet (1996) 1.69

Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am (1981) 1.69

Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet (1999) 1.69

Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2008) 1.69

Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med (1992) 1.68

Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum Mol Genet (2001) 1.68

Challenge test battery in chronic urticaria. Br J Dermatol (1976) 1.67

Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med (1999) 1.67

A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg (1988) 1.66

Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling. Proc Natl Acad Sci U S A (1975) 1.65

Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet (1998) 1.63

Why retrobulbar anaesthesia? Br J Ophthalmol (1988) 1.63

Mutants of Anabaena cylindrica altered in heterocyst spacing. Arch Microbiol (1975) 1.62

A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment. J Med Genet (2001) 1.61

Related cell-surface antigens expressed with positional specificity in Drosophila imaginal discs. Proc Natl Acad Sci U S A (1984) 1.60

Ten per cent polarized optical emission from GRB 090102. Nature (2009) 1.58

Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. Neurology (2005) 1.57

Highly polarized light from stable ordered magnetic fields in GRB 120308A. Nature (2013) 1.57

Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors. J Nucl Med (2001) 1.56

Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) (2006) 1.55

Giant-cell tumors of the bones of the hand. J Hand Surg Am (1980) 1.55

Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet (1999) 1.54

Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest (1994) 1.53

Increased intestinal permeability associated with infection in burn patients. Arch Surg (1988) 1.53

Rapid methods to extract DNA and RNA from Cryptococcus neoformans. FEMS Yeast Res (2001) 1.52

Abnormal movement of the arytenoid region during exercise presenting as exercise-induced asthma in an adolescent athlete. Chest (1994) 1.52

Methotrexate in juvenile idiopathic arthritis: answers and questions. J Rheumatol (2000) 1.51

A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet (2001) 1.49

ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun (1994) 1.48

The Lang lecture 1986. The enigma of primary open-angle glaucoma. Trans Ophthalmol Soc U K (1986) 1.48

Allometric scaling in comparative biology: problems of concept and method. Am J Physiol (1984) 1.48

[ The family physician's sentinel function studied with reference to referrals and referral cards]. Ned Tijdschr Geneeskd (1996) 1.47

Antiphospholipid antibodies in paediatrics. Eur J Pediatr (1994) 1.46

Effect of fluvastatin on lipids and fibrinolysis in coronary artery disease. Am J Cardiol (1997) 1.46

Endobronchial tumors in children: an uncommon clinical entity. Ann Otol Rhinol Laryngol (2001) 1.45

Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents. J Med Chem (1993) 1.45

Factor V Leiden mutation in a case with ischemic stroke: which relationship? A case report. Angiology (1998) 1.45

Identification of novel USH2A mutations: implications for the structure of USH2A protein. Eur J Hum Genet (2000) 1.45

Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry (2011) 1.44

Three newly delimited species of Saccharomyces sensu stricto. Antonie Van Leeuwenhoek (1987) 1.43

Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet (1997) 1.42

Management of congenital buccopharyngeal membrane. Cleft Palate Craniofac J (1997) 1.39

Study finds sleeping pills overprescribed. Science (1979) 1.39

Clinical and molecular genetics of Usher syndrome. J Am Acad Audiol (1995) 1.38

Vertebral and carotid artery dissection following chiropractic cervical manipulation. Neurosurg Rev (1999) 1.38

Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J Biol Chem (1998) 1.37

Nematoda from the terrestrial deep subsurface of South Africa. Nature (2011) 1.37

Linkage of a gene for dominant non-syndromic deafness to chromosome 19. Hum Mol Genet (1995) 1.36